Aspire Biosciences facilitates the development of treatments for rare diseases by establishing structured partnerships between patient advocacy groups and R&D companies. The company employs a methodology called Systematic Serendipity, guiding patient teams through data collection, discovery, and development processes. This approach connects patient needs with relevant industry assets to generate viable therapeutic opportunities.
Funding
Funding not disclosed
Founders
Product
Problem
Over 7,000 rare diseases lack effective treatments, leaving 95% of rare disease patients without therapeutic options. Traditional research and development approaches often fail to address these conditions due to limited patient populations and data scarcity.
Solution
Aspire Biosciences employs a "Systematic Serendipity" methodology to accelerate the development of treatments for rare diseases. The company facilitates partnerships between patient groups, researchers, and pharmaceutical companies to foster data collection, discovery, and development processes. By connecting unmet medical needs with potential therapeutic solutions, Aspire Biosciences aims to bridge the gap in rare disease treatment. They guide patient groups in data collection and introduce them to relevant companies and assets to generate opportunities for collaboration and treatment development.
Target Audience
Aspire Biosciences primarily serves patient groups affected by rare diseases, pharmaceutical and biotechnology companies, researchers, and entrepreneurs seeking to develop treatments for rare conditions.
Features
- Facilitates team building between patient group representatives and clinical/scientific advisors.
- Guides patient groups on data collection, discovery, and development strategies.
- Introduces companies and relevant assets to patient group teams to generate partnering opportunities.
- Nurtures working partnerships and provides ongoing support as needed.
- Organizes partnering cohorts to create in-person networking opportunities.
- Employs human searches to connect patient groups, pharma/biotech companies, researchers, and entrepreneurs.
- Utilizes machine searches with algorithms to match patient needs and solutions.